Literature DB >> 15722540

Real-time reverse transcriptase PCR for the endogenous koala retrovirus reveals an association between plasma viral load and neoplastic disease in koalas.

Rachael Tarlinton1, Joanne Meers2, Jon Hanger3, Paul Young1.   

Abstract

Koala retrovirus (KoRV) is a newly described endogenous retrovirus and is unusual in that inserts comprise a full-length replication competent genome. As koalas are known to suffer from an extremely high incidence of leukaemia/lymphoma, the association between this retrovirus and disease in koalas was examined. Using quantitative real-time reverse transcriptase PCR it was demonstrated that KoRV RNA levels in plasma are significantly increased in animals suffering from leukaemia or lymphoma when compared with healthy animals. Increased levels of KoRV were also seen for animals with clinical chlamydiosis. A significant positive association between viral RNA levels and age was also demonstrated. Real-time PCR demonstrated as much as 5 log variation in KoRV proviral DNA levels in genomic DNA extracted from whole blood from different animals. Taken together these data indicate that KoRV is an active endogenous retrovirus and suggests that it may be causally linked to neoplastic disease in koalas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722540     DOI: 10.1099/vir.0.80547-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  64 in total

1.  Changes in viral protein function that accompany retroviral endogenization.

Authors:  Nidia M Oliveira; Harshita Satija; I Arlette Kouwenhoven; Maribeth V Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

2.  Detection and Differentiation of Two Koala Gammaherpesviruses by Use of High-Resolution Melt (HRM) Analysis Reveals Differences in Viral Prevalence and Clinical Associations in a Large Study of Free-Ranging Koalas.

Authors:  P K Vaz; A R Legione; C A Hartley; J M Devlin
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

3.  Development and application of two multiplex real-time PCR assays for detection and speciation of bacterial pathogens in the koala.

Authors:  Lyndal S Hulse; Danica Hickey; Jessica M Mitchell; Kenneth W Beagley; William Ellis; Stephen D Johnston
Journal:  J Vet Diagn Invest       Date:  2018-04-09       Impact factor: 1.279

4.  Proliferation of endogenous retroviruses in the early stages of a host germ line invasion.

Authors:  Yasuko Ishida; Kai Zhao; Alex D Greenwood; Alfred L Roca
Journal:  Mol Biol Evol       Date:  2014-09-25       Impact factor: 16.240

5.  Characterisation of MHC class I genes in the koala.

Authors:  Yuanyuan Cheng; Adam Polkinghorne; Amber Gillett; Elizabeth A Jones; Denis O'Meally; Peter Timms; Katherine Belov
Journal:  Immunogenetics       Date:  2017-07-01       Impact factor: 2.846

6.  Tracking the Fate of Endogenous Retrovirus Segregation in Wild and Domestic Cats.

Authors:  Minh Ha Ngo; MaríaCruz Arnal; Ryosuke Sumi; Junna Kawasaki; Ariko Miyake; Chris K Grant; Takeshige Otoi; Daniel Fernández de Luco; Kazuo Nishigaki
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

7.  Phylogenetic Diversity of Koala Retrovirus within a Wild Koala Population.

Authors:  K J Chappell; J C Brealey; A A Amarilla; D Watterson; L Hulse; C Palmieri; S D Johnston; E C Holmes; J Meers; P R Young
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

8.  In vitro characterization of a koala retrovirus.

Authors:  Nidia M Oliveira; Karen B Farrell; Maribeth V Eiden
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Immunomics of the koala (Phascolarctos cinereus).

Authors:  Kendra C Abts; Jamie A Ivy; J Andrew DeWoody
Journal:  Immunogenetics       Date:  2015-03-13       Impact factor: 2.846

10.  Construction and characterization of an infectious molecular clone of Koala retrovirus.

Authors:  Takayuki Shojima; Shigeki Hoshino; Masumi Abe; Jiro Yasuda; Hiroko Shogen; Takeshi Kobayashi; Takayuki Miyazawa
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.